Kanada - anglų - Health Canada

lancome canada - ensulizole; octinoxate - lotion - 2%; 7.5% - ensulizole 2%; octinoxate 7.5% - sunscreen agents

Kanada - anglų - Health Canada

lancome canada - ensulizole; octinoxate - cream - 1.8%; 7.5% - ensulizole 1.8%; octinoxate 7.5% - sunscreen agents

Kanada - anglų - Health Canada

lancome canada - ensulizole; octinoxate - lotion - 2%; 7.5% - ensulizole 2%; octinoxate 7.5% - sunscreen agents

Kanada - anglų - Health Canada

dentsply canada limited - articaine hydrochloride; epinephrine (epinephrine bitartrate) - solution - 40mg; 0.01mg - articaine hydrochloride 40mg; epinephrine (epinephrine bitartrate) 0.01mg - local anesthetics

Kanada - anglų - Health Canada

dentsply canada limited - prilocaine hydrochloride; epinephrine - solution - 40mg; 0.005mg - prilocaine hydrochloride 40mg; epinephrine 0.005mg - local anesthetics

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

woodward pharma services llc - chlorambucil (unii: 18d0sl7309) (chlorambucil - unii:18d0sl7309) - leukeran (chlorambucil) is indicated in the treatment of chronic lymphatic (lymphocytic) leukemia, malignant lymphomas including lymphosarcoma, giant follicular lymphoma, and hodgkin’s disease. it is not curative in any of these disorders but may produce clinically useful palliation. chlorambucil should not be used in patients whose disease has demonstrated a prior resistance to the agent. patients who have demonstrated hypersensitivity to chlorambucil should not be given the drug. there may be cross-hypersensitivity (skin rash) between chlorambucil and other alkylating agents.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

aspen global inc. - chlorambucil (unii: 18d0sl7309) (chlorambucil - unii:18d0sl7309) - chlorambucil 2 mg - leukeran (chlorambucil) is indicated in the treatment of chronic lymphatic (lymphocytic) leukemia, malignant lymphomas including lymphosarcoma, giant follicular lymphoma, and hodgkin’s disease. it is not curative in any of these disorders but may produce clinically useful palliation. chlorambucil should not be used in patients whose disease has demonstrated a prior resistance to the agent. patients who have demonstrated hypersensitivity to chlorambucil should not be given the drug. there may be cross-hypersensitivity (skin rash) between chlorambucil and other alkylating agents.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

waylis therapeutics llc - chlorambucil (unii: 18d0sl7309) (chlorambucil - unii:18d0sl7309) - leukeran (chlorambucil) is indicated in the treatment of chronic lymphatic (lymphocytic) leukemia, malignant lymphomas including lymphosarcoma, giant follicular lymphoma, and hodgkin’s disease. it is not curative in any of these disorders but may produce clinically useful palliation. chlorambucil should not be used in patients whose disease has demonstrated a prior resistance to the agent. patients who have demonstrated hypersensitivity to chlorambucil should not be given the drug. there may be cross-hypersensitivity (skin rash) between chlorambucil and other alkylating agents.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

washington homeopathic products - ptelea - to relieve the symptoms of headache. indications: ptelea   headache if symptoms persist/worsen or if pregnant/nursing, stop use and consult your practitioner.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

washington homeopathic products - ptelea - to relieve the symptoms of headache. indications:  ptelea   headache if symptoms persist/worsen or if pregnant/nursing, consult your practitioner.